NasdaqGS:TECHLife Sciences
Bio-Techne (TECH): Reassessing Valuation After Strong Earnings and New Product Launches
Bio-Techne (TECH) just released its first-quarter earnings, reporting a jump in net income and earnings per share, even as sales dipped slightly year over year. Alongside earnings, several recent company updates stand out.
See our latest analysis for Bio-Techne.
Despite Bio-Techne's surge in innovation, from AI-driven biomarker advances unveiled at recent conferences to steady progress on share buybacks and dividends, the stock has yet to spark a reversal in momentum. The 1-year total...